ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Myositis"

  • Abstract Number: 1075 • ACR Convergence 2020

    Diagnostic Utility of Myositis Antibodies in HyperCKemia: A University Affiliated Single Center Retrospective Study

    Sandeepkumar Gupta1, Debendra Pattanaik2, Tulio Bertorini2 and Amado Afreire3, 1Medical College Of Georgia at Augusta University Medical Center, Augusta, GA, 2University of Tennessee Health Science Center, Memphis, TN, 3University of Tennessee Health Science Cente, Memphis, TN

    Background/Purpose: Myositis specific and associated autoantibodies are now being used more frequently in the diagnosis of idiopathic inflammatory myositis. However there is a no study…
  • Abstract Number: 1096 • ACR Convergence 2020

    Assessing Interstitial Lung Disease in a Racially Diverse Population with Idiopathic Inflammatory Myositis

    Jammie Law1, Ana Valle2, Katherine Mullins3 and Shereen Mahmood4, 1Montefiore Medical Center, Bronx, NY, 2Albert Einstein College of Medicine, New York, NY, 3Montefiore Medical Center, BROOKLYN, NY, 4Albert Einstein College of Medicine / Montefiore Medical Center, Wantagh, NY

    Background/Purpose: Interstitial lung disease (ILD) is a common extra-muscular manifestation of Idiopathic Inflammatory Myositis (IIM) and increases risk of mortality. Prior studies and registries have focused on either smaller cohorts or predominantly Caucasian/European populations. Our aim was to better characterize the…
  • Abstract Number: 1055 • ACR Convergence 2020

    Myositis and Systemic Sclerosis Spectrum IPAF Patients Are More Likely to Respond Favorably to Immunosuppression

    Erin Wilfong1, Gabriel Schroeder1, April Barnado1, Steven Lord1, Narender Annapureddy1, Rosemarie Dudenhofer1 and Leslie J. Crofford1, 1Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Classification criteria for interstitial pneumonia with autoimmune features (IPAF) were introduced in 2015 to identify interstitial lung disease (ILD) patients who might benefit from…
  • Abstract Number: 1076 • ACR Convergence 2020

    Anti-Jo1 Antibody Quantification Serve as a Prognostic Factor in Anti-synthetase Syndrom

    Lois Bolko1, Kevin Didier2, Jean-Hugues Salmon1, Makoto Miyara3, Segolene Toquet2, Amelie Servettaz2, Yves Allenbach3, Olivier Benveniste4 and Baptiste Hervier5, 1Maison Blanche Hospital, Reims, Champagne-Ardenne, France, 2Robert Debre Hospital, Reims, Champagne-Ardenne, France, 3Sorbonne Université, Paris, Ile-de-France, France, 4Sorbonne Université, paris, France, 5Saint-Louis Hospital, Paris, Ile-de-France, France

    Background/Purpose: Anti-Synthetase Syndrome (ASyS) is a rare systemic autoimmune disease defined by a combination of pulmonary, muscle, joint, and skin manifestations and the presence of…
  • Abstract Number: 1098 • ACR Convergence 2020

    Anti-cortactin Autoantibodies Are Associated with Key Clinical Features in Adult Myositis but Are Rarely Present in Juvenile Myositis

    Iago Pinal-Fernandez1, Katherine Pak2, Albert Gil-Vila3, Andres Baucells4, Benjamin Plotz5, Maria Casal-Dominguez6, Assia Derfoul7, Maria Angeles Martinez4, Albert Selva-O'Callaghan3, Sara Sabbagh8, Frederick W. Miller1, Lisa G. Rider9, Lisa Christopher-Stine10 and Andrew Mammen6, 1National Institutes of Health, Bethesda, MD, 2NIAMS, NIH, Bethesda, MD, 3Vall d’Hebron Hospital, Barcelona, Spain, 4Sant Pau Hospital, Barcelona, Spain, 5Division of Rheumatology, New York University Langone Health, New York, NY, 6NIH, Bethesda, MD, 7NIAMS, NIH, Bethesda, 8Division of Rheumatology, Department of Pediatrics, Medical College of Wisconsin, Washington, DC, 9Environmental Autoimmunity Group, Clinical Research Branch, NIEHS, NIH, Garrett Park, MD, 10Johns Hopkins University, Baltimore, MD

    Background/Purpose: To define the prevalence and clinical phenotype of anti-cortactin autoantibodies in adult and juvenile myositis.Methods: In this longitudinal cohort study, anti-cortactin autoantibody tiers were…
  • Abstract Number: 1056 • ACR Convergence 2020

    Descriptive Data Analysis of Patients with Anti Jo1 Syndrome (AJS) and Lung Involvement

    Mohamed Alalwani1, Bassam Alhaddad2, Basem Zraik3, Christopher O'Rourke3, Ruchi Yadav3, Ali Askari1, Charles Malemud1 and Soumya Chatterjee4, 1Case Western Reserve University / University Hospitals Cleveland Medical Center, Cleveland, OH, 2MetroHealth Medical Center, Westlake, OH, 3Cleveland Clinic, Cleveland, OH, 4Cleveland Clinic, Richmond Heights, OH

    Background/Purpose: To evaluate the patterns, severity and, prognostic parameters of interstitial lung disease (ILD) in Anti Jo1 Syndrome (AJS).Methods: We identified 51 anti-Jo-1 patients with…
  • Abstract Number: 1077 • ACR Convergence 2020

    Glucagon-like Peptide-1 Receptor Agonist Suppresses Muscle Inflammation and Muscle Fiber Death, and Ameliorates Muscle Weakness in Experimental Polymyositis

    Mari Kamiya1, Seon Uk Kim2, Jeong Yeon Kim3, Shinsuke Yasuda4, Eun Young Lee5 and Fumitaka Mizoguchi1, 1Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan, 2Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Jongno-gu, Seoul, Republic of Korea, 3Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, 4Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Tokyo, Japan, 5Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

    Background/Purpose: Glucocorticoids (GC) are the cornerstone of the treatment for polymyositis (PM). However, the treatment with GC causes GC-induced myopathy, which further deteriorates the muscle…
  • Abstract Number: 1099 • ACR Convergence 2020

    High Burden of Infections in Indian Patients with Idiopathic Inflammatory Myopathy: Validation of Observations from the MyoCite Dataset

    Rudrarpan Chatterjee1, Pankti Mehta2, Vikas Agarwal1 and Latika Gupta2, 1Sanjay Gandhi Post Graduate Institute of Medical Sciences, lucknow, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Background/Purpose: Infections are a major cause of morbidity and mortality in idiopathic inflammatory myopathy (IIM), more so in India.[1-3] The objective of this study was…
  • Abstract Number: 1057 • ACR Convergence 2020

    Earlier Cancer Diagnosis After Idiopathic Inflammatory Myopathy Onset Is Associated with Improved Long Term Survival – Results from Four European Cohorts

    Alexander Oldroyd1, Paul New2, Janine Lamb1, William Ollier1, Robert Cooper2, Kuberacka Mariampillai3, Olivier Benveniste3, Jiří Vencovský4, Heřman Mann5, Zoltan Griger6, Melinda Nagy-Vincze6, Katalin Dankó6 and Hector Chinoy7, 1University of Manchester, Manchester, United Kingdom, 2University of Liverpool, Liverpool, United Kingdom, 3Sorbonne Université, Paris, France, 4Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 5Institute of Rheumatology, Prague, Czech Republic. Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 6University of Debrecen, Debrecen, Hungary, 7The University of Manchester, Manchester, United Kingdom

    Background/Purpose: The idiopathic inflammatory myopathies (IIMs) are strongly associated with the development of clinically detectable cancer. Cancer screening has therefore been advocated in newly diagnosed…
  • Abstract Number: 1078 • ACR Convergence 2020

    Highly Reactive anti-Jo1 Autoantibodies to Distinct HisRS Variants and Domains Associate with Lung and Joint Involvement in Patients with Myositis

    Antonella Notarnicola1, Charlotta Preger2, Susanna L. Lundström2, Nuria Renard2, Edvard Wigren2, Eveline Van Gompel2, Angeles S. Galindo-Feria2, Helena Persson3, Maryam Fathi4, Johan Grunewald2, Per-Johan Jakobsson2, Susanne Gräslund2, Ingrid Lundberg5 and Cátia Fernandes-Cerqueira2, 1Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 2Karolinska Institutet, stockholm, Sweden, 3Science for Life Laboratories, KTH, Stockholm, Sweden, 4Karolinska University Hospital, stockholm, Sweden, 5Division of Rheumatology, Department of Medicine, Karolinska Institutet,, Stockholm, Sweden

    Background/Purpose: To address the reactivity and affinity against histidyl-transfer RNA synthetase (HisRS) autoantigen of anti-Jo1 autoantibodies from serum and bronchoalveolar lavage fluid (BALF) and associations…
  • Abstract Number: 1457 • ACR Convergence 2020

    Two Minute Walking Distance and Other Timed Function Tests Are Superior to MMT-8 in Assessing Outcomes in Polymyositis and Dermatomyositis

    Sai kumar Dunga1, Chengappa G Kavadichanda2 and VS Negi2, 1Jawaharlal institute of postgraduate medical education and research, puducherry, India, 2Jawaharlal institute of postgraduate medical education and research, Puducherry, Puducherry, India

    Background/Purpose: Inflammatory myositis are heterogenous group of diseases affecting skeletal muscles and multiple different organs. Assessing improvement in disease activity is done by Manual muscle…
  • Abstract Number: 1059 • ACR Convergence 2020

    Anti-mitochondrial Autoantibodies Are Associated with Cardiomyopathy, Dysphagia, and Features of More Severe Disease in Adult-onset Myositis

    Sara Sabbagh1, Iago Pinal-Fernandez2, Maria Casal-Dominguez3, Jemima Albayda4, Julie Paik4, Frederick W. Miller2, Lisa G. Rider5, Andrew Mammen3 and Lisa Christopher-Stine4, 1Medical College of Wisconsin, Fox Point, WI, 2National Institutes of Health, Bethesda, MD, 3NIH, Bethesda, MD, 4Johns Hopkins University, Baltimore, MD, 5Environmental Autoimmunity Group, Clinical Research Branch, NIEHS, NIH, Garrett Park, MD

    Background/Purpose: We examined the prevalence of anti-mitochondrial autoantibodies (AMA) in adult- and juvenile-onset myositis longitudinal cohorts and investigated phenotypic differences between myositis patients with or…
  • Abstract Number: 1079 • ACR Convergence 2020

    Sex Differences in Antibody Profile, Phenotype, and Treatment Response in a Racially Diverse Population with Idiopathic Inflammatory Myopathies

    Ana Valle1, Jammie Law2, Katherine Mullins3 and Shereen Mahmood4, 1Albert Einstein College of Medicine, New York, NY, 2Montefiore Medical Center, Bronx, NY, 3Montefiore Medical Center, BROOKLYN, NY, 4Albert Einstein College of Medicine / Montefiore Medical Center, Wantagh, NY

    Background/Purpose: It is established that autoimmune diseases are more common in females than males. Large scale idiopathic inflammatory myopathy (IIM) registries have shown a similar…
  • Abstract Number: 1556 • ACR Convergence 2020

    Assessing Calcinosis in Dermatomyositis with Computed Tomography and Calcium Scoring

    Prateek Gowda1, Briana Cervantes2, Lisa G. Rider3, Frederick W. Miller4, Marcus Chen4 and Adam Schiffenbauer4, 1NIBIB, Baltimore, MD, 2NIEHS, Silver Spring, MD, 3Environmental Autoimmunity Group, Clinical Research Branch, NIEHS, NIH, Garrett Park, MD, 4National Institutes of Health, Bethesda, MD

    Background/Purpose: Calcinosis is a condition in which calcium salts are deposited in and around soft tissue and is observed in up to 30% of adult…
  • Abstract Number: 1060 • ACR Convergence 2020

    B-cell-rich Inflammatory Myopathies in Adults: Striking Association with Connective Tissue Diseases

    Pat Korathanakhun1, Océane Landon-Cardinal2, Valérie Leclair3, Benjamin Ellezam4, Alain Meyer5, Josiane Bourré-Tessier2, Anne-Marie Mansour6, Sandrine Larue7, François Grand'Maison7, Rami Massie8, Matthieu Le Page9, Catherine Isabelle7, Nathalie Routhier6, Flavie Roy10, Minoru Satoh11, Marvin Fritzler12, Jean-Luc Senécal2, Yves Troyanov13, Marie Hudson3, Jason Karamchandani14 and Erin O'Ferrall8, 1Montreal Neurological Institute and Hospital, Montreal, QC, Canada, 2Division of Rheumatology, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada, 3Division of Rheumatology, Jewish General Hospital, Montréal, QC, Canada, 4Division of Pathology, Centre hospitalier universitaire Sainte-Justine, Montréal, QC, Canada, 5Service de rhumatologie et Centre de références des maladies autoimmunes rares, Hôpitaux universitaires de Strasbourg, Strasbourg, France, 6Hôpital du Sacré-Coeur de Montréal, Montreal, QC, Canada, 7Hôpital Charles-Lemoyne, Longueuil, QC, Canada, 8Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, Montreal, QC, Canada, 9Centre hospitalier de Lanaudière, Saint-Charles-Borromée, QC, Canada, 10Uiversité de Montréal, Montreal, QC, Canada, 11Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan, 12Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 13Division of Rheumatology, Hôpital du Sacré-Coeur, Montréal, QC, Canada, 14Department of Pathology, Montreal Neurological Institute and Hospital, Montreal, QC, Canada

    Background/Purpose: Myositis with significant B-cell infiltrates on muscle biopsy has scarcely been described in adults. Radke (2018) found B cells in adult dermatomyositis (DM) and…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 28
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology